Over the last week, we have seen a host of announced mergers and acquisition. Taken together, in my opinion, these would harken some scary conclusions.
Buy me to the moon?
In the last week alone, we saw three acquisitions announced that show how fiercely these companies want to be bigger. It all seems about becoming the titan of the industry. If NASA and Roscosmos (Russia’s space agency) are both looking to fly manned missions back to the moon, these different corporate management teams are looking to buy me to the moon.
- Allergan and Pfizer merger would make a combined entity with over $300 billion in valuation (WSJ) – 29 October. This comes on the heels of Pfizer’s acquisition of Hospira earlier this year (for $15 billion – Guardian)
- Hyatt ($7 billion valuation) is apparently targeting the acquisition of Starwood Hotels (c $13.5 billion valuation) – 28 October via CNBC
- Walgreen to buy Rite-Aid ($17.2 billion) – October 28 via USA Today
Earlier in the year, we had many other huge merger & acquisitions announced or completed: Continue reading